![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | St6galnac3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:32109520 | St6galnac3 | Rat | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | St6galnac3 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:28522335 | St6galnac3 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | St6galnac3 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:18648102 | St6galnac3 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:18077114 and PMID:30047161 | St6galnac3 | Rat | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of ST6GALNAC3 mRNA | CTD | PMID:24780913 | St6galnac3 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:28959563 | St6galnac3 | Rat | aflatoxin B1 | decreases methylation | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ST6GALNAC3 gene | CTD | PMID:27153756 | St6galnac3 | Rat | aflatoxin M1 | decreases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:30928695 | St6galnac3 | Rat | all-trans-retinoic acid | multiple interactions | ISO | St6galnac3 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:36189433 | St6galnac3 | Rat | all-trans-retinoic acid | increases expression | ISO | St6galnac3 (Mus musculus) | 6480464 | Tretinoin results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:36189433 | St6galnac3 | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:30047161 | St6galnac3 | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:30779732 | St6galnac3 | Rat | aristolochic acid A | decreases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:33212167 | St6galnac3 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of ST6GALNAC3 gene | CTD | PMID:35440735 | St6galnac3 | Rat | benzo[a]pyrene | decreases expression | ISO | St6galnac3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:21569818 | St6galnac3 | Rat | benzo[a]pyrene | decreases methylation | ISO | St6galnac3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of ST6GALNAC3 intron | CTD | PMID:27901495 | St6galnac3 | Rat | benzo[a]pyrene | increases methylation | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ST6GALNAC3 exon and Benzo(a)pyrene results in increased methylation of ST6GALNAC3 promoter | CTD | PMID:27901495 | St6galnac3 | Rat | benzo[a]pyrene | increases expression | ISO | St6galnac3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:32417428 | St6galnac3 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:25181051 and PMID:30816183 | St6galnac3 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ST6GALNAC3 gene | CTD | PMID:28505145 | St6galnac3 | Rat | buta-1,3-diene | decreases expression | ISO | St6galnac3 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:29038090 | St6galnac3 | Rat | carbamazepine | affects expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ST6GALNAC3 mRNA | CTD | PMID:25979313 | St6galnac3 | Rat | chloroprene | decreases expression | ISO | St6galnac3 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:23125180 | St6galnac3 | Rat | cisplatin | decreases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:27392435 | St6galnac3 | Rat | cisplatin | multiple interactions | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:27392435 | St6galnac3 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:27523638 | St6galnac3 | Rat | cytarabine | decreases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Cytarabine results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:21198554 | St6galnac3 | Rat | Dibutyl phosphate | affects expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of ST6GALNAC3 mRNA | CTD | PMID:37042841 | St6galnac3 | Rat | dimethylarsinic acid | multiple interactions | ISO | St6galnac3 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:34876320 | St6galnac3 | Rat | dioxygen | multiple interactions | ISO | St6galnac3 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ST6GALNAC3 mRNA | CTD | PMID:30529165 | St6galnac3 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:21551480 | St6galnac3 | Rat | dorsomorphin | multiple interactions | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:27188386 | St6galnac3 | Rat | doxorubicin | affects methylation | EXP | | 6480464 | Doxorubicin affects the methylation of ST6GALNAC3 gene | CTD | PMID:28962528 | St6galnac3 | Rat | doxorubicin | decreases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:29803840 | St6galnac3 | Rat | ethanol | affects expression | ISO | St6galnac3 (Mus musculus) | 6480464 | Ethanol affects the expression of ST6GALNAC3 mRNA | CTD | PMID:30319688 | St6galnac3 | Rat | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:18035473 | St6galnac3 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of ST6GALNAC3 gene | CTD | PMID:35440735 | St6galnac3 | Rat | methylarsonic acid | multiple interactions | ISO | St6galnac3 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:34876320 | St6galnac3 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | St6galnac3 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:36189433 | St6galnac3 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:25729387 | St6galnac3 | Rat | ozone | multiple interactions | ISO | St6galnac3 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:27106289 | St6galnac3 | Rat | paracetamol | affects expression | ISO | St6galnac3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ST6GALNAC3 mRNA | CTD | PMID:17562736 | St6galnac3 | Rat | pentanal | increases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | pentanal results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:26079696 | St6galnac3 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | St6galnac3 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:37995155 | St6galnac3 | Rat | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:19162173 | St6galnac3 | Rat | pirinixic acid | multiple interactions | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:19710929 | St6galnac3 | Rat | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:30047161 | St6galnac3 | Rat | rotenone | increases expression | ISO | St6galnac3 (Mus musculus) | 6480464 | Rotenone results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:32937126 | St6galnac3 | Rat | SB 431542 | multiple interactions | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:27188386 | St6galnac3 | Rat | sodium arsenate | multiple interactions | ISO | St6galnac3 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:34876320 | St6galnac3 | Rat | sodium arsenite | increases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:38568856 | St6galnac3 | Rat | sodium arsenite | multiple interactions | ISO | St6galnac3 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:34876320 | St6galnac3 | Rat | sodium arsenite | decreases expression | ISO | St6galnac3 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:32068019 | St6galnac3 | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:30047161 | St6galnac3 | Rat | sunitinib | decreases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:31533062 | St6galnac3 | Rat | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of ST6GALNAC3 mRNA | CTD | PMID:15963342 | St6galnac3 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ST6GALNAC3 mRNA | CTD | PMID:25729387 | St6galnac3 | Rat | triclosan | increases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Triclosan results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:30510588 | St6galnac3 | Rat | triphenyl phosphate | affects expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ST6GALNAC3 mRNA | CTD | PMID:37042841 | St6galnac3 | Rat | valproic acid | affects expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ST6GALNAC3 mRNA | CTD | PMID:25979313 | St6galnac3 | Rat | valproic acid | increases expression | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:23179753 more ... | St6galnac3 | Rat | valproic acid | multiple interactions | ISO | ST6GALNAC3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST6GALNAC3 mRNA | CTD | PMID:27188386 | St6galnac3 | Rat | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of ST6GALNAC3 gene | CTD | PMID:31079544 | |